Publication | Closed Access

Antagonistic activities of N-3389, a newly synthetized diazabicyclo derivative, at 5-HT3 and 5-HT4 receptors

Diazabicyclo DerivativeDrug TargetBiochemistryFunctional SelectivityMedicineAntagonistic ActivitiesNatural SciencesMechanism Of Action5-Ht4 ReceptorsPharmacotherapyChemical BiologyPharmacologyDrug Discovery